Cardio Diagnostics Holdings Stock Alpha and Beta Analysis
| CDIOW Stock | USD 0.02 0 18.46% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Cardio Diagnostics Holdings. It also helps investors analyze the systematic and unsystematic risks associated with investing in Cardio Diagnostics over a specified time horizon. Remember, high Cardio Diagnostics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Cardio Diagnostics' market risk premium analysis include:
Beta 0.12 | Alpha 0.16 | Risk 10.03 | Sharpe Ratio (0.01) | Expected Return (0.06) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Cardio Diagnostics Backtesting, Cardio Diagnostics Valuation, Cardio Diagnostics Correlation, Cardio Diagnostics Hype Analysis, Cardio Diagnostics Volatility, Cardio Diagnostics History and analyze Cardio Diagnostics Performance. Cardio Diagnostics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Cardio Diagnostics market risk premium is the additional return an investor will receive from holding Cardio Diagnostics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Cardio Diagnostics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Cardio Diagnostics' performance over market.| α | 0.16 | β | 0.12 |
Cardio Diagnostics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Cardio Diagnostics' Buy-and-hold return. Our buy-and-hold chart shows how Cardio Diagnostics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Cardio Diagnostics Market Price Analysis
Market price analysis indicators help investors to evaluate how Cardio Diagnostics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cardio Diagnostics shares will generate the highest return on investment. By understating and applying Cardio Diagnostics stock market price indicators, traders can identify Cardio Diagnostics position entry and exit signals to maximize returns.
| Price Series Summation | ||
| Price Series Division | ||
| Inverse Tangent Over Price Movement | ||
| Price Ceiling Movement | ||
| Aroon Oscillator | ||
| Balance Of Power | ||
| All Moving Average | ||
| MESA Adaptive Moving Average | ||
| Belt hold | ||
| Hanging Man |
Cardio Diagnostics Return and Market Media
The median price of Cardio Diagnostics for the period between Thu, Oct 30, 2025 and Wed, Jan 28, 2026 is 0.0201 with a coefficient of variation of 11.03. The daily time series for the period is distributed with a sample standard deviation of 0.0, arithmetic mean of 0.02, and mean deviation of 0.0. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Acquisition by Burton Paul Frederick of 1736 shares of Cardio Diagnostics at 3.6 subject to Rule 16b-3 | 10/10/2025 |
2 | Is Cardio Diagnostics Holdings Inc. stock poised for growth - 2025 Breakouts Breakdowns Weekly Chart Analysis and Trade Guides - newser.com | 10/21/2025 |
3 | Cardio Diagnostics presents AUC 0.90 INOCA results for PrecisionCHD at AHA - Stock Titan | 11/05/2025 |
4 | CMS sets final payment rate of 854 for Cardio Diagnostics tests - Investing.com Nigeria | 12/03/2025 |
5 | Acquisition by Burton Paul Frederick of 2306 shares of Cardio Diagnostics at 2.71 subject to Rule 16b-3 | 12/31/2025 |
6 | Disposition of tradable shares by Levy Oded of Cardio Diagnostics subject to Rule 16b-3 | 01/02/2026 |
7 | 12 Health Care Stocks Moving In Wednesdays Pre-Market Session - Benzinga | 01/07/2026 |
About Cardio Diagnostics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Cardio or other stocks. Alpha measures the amount that position in Cardio Diagnostics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2024 | 2025 | 2026 (projected) | Days Sales Outstanding | 194.71 | 175.24 | 120.32 | PTB Ratio | 77.41 | 89.02 | 84.57 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cardio Diagnostics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cardio Diagnostics' short interest history, or implied volatility extrapolated from Cardio Diagnostics options trading.
Build Portfolio with Cardio Diagnostics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Cardio Stock Analysis
When running Cardio Diagnostics' price analysis, check to measure Cardio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardio Diagnostics is operating at the current time. Most of Cardio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Cardio Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardio Diagnostics' price. Additionally, you may evaluate how the addition of Cardio Diagnostics to your portfolios can decrease your overall portfolio volatility.